Floriana Morgillo - Concepedia

Author

Floriana Morgillo

University of Campania "Luigi Vanvitelli"ORCID

Also Known As

F Morgillo, F. Morgillo, FLORIANA MORGILLO, Floriana Morgillo, Floriana Morgillo (337840), Morgillo, Floriana, Seung Hyun Oh

385

Publications

9.7K

Citations

H-Index

Concepts

All Affiliations

University of Campania "Luigi Vanvitelli"University of Naples Federico II Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"The University of Texas MD Anderson Cancer Center Azienda Ospedaliera S.Giuseppe Moscati

About

Floriana Morgillo is an author at University of Campania "Luigi Vanvitelli" specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	27	979
2	Cell Biology	9	9	321
3	Health Sciences	6	6	195
4	Engineering	1	1	15
5	Health Informatics	1	1	20

Floriana Morgillo

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib Floriana Morgillo, Jong Kyu Woo, Edward S. Kim, Cancer Research	2006	335
Implication of the Insulin-like Growth Factor-IR Pathway in the Resistance of Non–small Cell Lung Cancer Cells to Treatment with Gefitinib Floriana Morgillo, Woo-Young Kim, Edward S. Kim, Clinical Cancer Research	2007	251
First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial Cesare Gridelli, Fortunato Ciardiello, Ciro Gallo, Journal of Clinical Oncology	2012	232
Increased TGF-α as a Mechanism of Acquired Resistance to the Anti-EGFR Inhibitor Cetuximab through EGFR–MET Interaction and Activation of MET Signaling in Colon Cancer Cells Teresa Troiani, Erika Martinelli, Stefania Napolitano, Clinical Cancer Research	2013	144
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer Carminia Maria Della Corte, Claudio Bellevicine, Giovanni Vicidomini, Clinical Cancer Research	2015	116
Synergistic Effects of Metformin Treatment in Combination with Gefitinib, a Selective EGFR Tyrosine Kinase Inhibitor, in LKB1 Wild-type NSCLC Cell Lines Floriana Morgillo, Ferdinando Carlo Sasso, Carminia Maria Della Corte, Clinical Cancer Research	2013	116
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma Ferdinando De Vita, Michele Orditura, Eva Lieto, Cancer	2004	113
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures Carminia Maria Della Corte, Giusi Barra, Vincenza Ciaramella, Journal of Experimental & Clinical Cancer Research	2019	105
Control of post-thoracotomy pain by transcutaneous electrical nerve stimulation: effect on serum cytokine levels, visual analogue scale, pulmonary function and medication Alfonso Fiorelli, Floriana Morgillo, Roberta Milione, European Journal of Cardio-Thoracic Surgery	2011	101
Primary and Acquired Resistance of Colorectal Cancer Cells to Anti-EGFR Antibodies Converge on MEK/ERK Pathway Activation and Can Be Overcome by Combined MEK/EGFR Inhibition Teresa Troiani, Stefania Napolitano, Donata Vitagliano, Clinical Cancer Research	2014	100

Page 1